Eskitis Institute, Griffith University, Nathan, Queensland 4111, Australia.
J Med Chem. 2011 Mar 24;54(6):1682-92. doi: 10.1021/jm1013242. Epub 2011 Feb 18.
In order to discover novel probes that may help in the investigation and control of infectious diseases through a new mechanism of action, we have evaluated a library of phenol-based natural products (NPs) for enzyme inhibition against four recently characterized pathogen β-family carbonic anhydrases (CAs). These include CAs from Mycobacterium tuberculosis, Candida albicans, and Cryptococcus neoformans as well as α-family human CA I and CA II for comparison. Many of the NPs selectively inhibited the mycobacterial and fungal β-CAs, with the two best performing compounds displaying submicromolar inhibition with a preference for fungal over human CA inhibition of more than 2 orders of magnitude. These compounds provide the first example of non-sulfonamide inhibitors that display β over α CA enzyme selectivity. Structural characterization of the library compounds in complex with human CA II revealed a novel binding mode whereby a methyl ester interacts via a water molecule with the active site zinc.
为了通过新的作用机制发现有助于传染病研究和控制的新型探针,我们评估了酚类天然产物(NPs)文库对四种最近表征的病原体β-家族碳酸酐酶(CA)的酶抑制作用。这些包括结核分枝杆菌、白色念珠菌和新型隐球菌的 CA,以及用于比较的α-家族人 CA I 和 CA II。许多 NPs 选择性抑制分枝杆菌和真菌β-CA,两种表现最好的化合物显示出亚微摩尔抑制,对真菌的抑制作用比对人 CA 的抑制作用高出两个数量级以上。这些化合物提供了首个显示β 对α CA 酶选择性的非磺胺类抑制剂的实例。与人类 CA II 结合的文库化合物的结构特征揭示了一种新的结合模式,其中甲酯通过水分子与活性位点锌相互作用。